![Shui On Leung](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Shui On Leung
Amministratore Delegato presso
SINOMAB BIOSCIENCE LIMITED
Patrimonio netto: 21 M $ in data 31/05/2026
Profilo
Shui On Leung is the founder of Sinomab Bioscience Ltd. since 2001, holding the title of Chairman & Chief Executive Officer.
Current job includes serving as Director at Hong Kong Genome Institute.
Former jobs include Associate Director-Molecular Biology Department at Immunomedics, Inc. from 1991 to 2000, Managing Director at The Hong Kong Institute of Biotechnology Ltd. from 2000 to 2003, and Director at Novelmab Ltd. from 2011 to 2018.
Education includes a doctorate from the University of Oxford conferred in 1989, an undergraduate degree from The Chinese University of Hong Kong conferred in 1984, a graduate degree from The Chinese University of Hong Kong conferred in 1986, and an MBA from The Chinese University of Hong Kong conferred in 2006.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 15/08/2025 | 129.729.200 ( 9,36% ) | 21 M $ | 31/05/2026 |
Posizioni attive di Shui On Leung
| Società | Posizione | Inizio |
|---|---|---|
| SINOMAB BIOSCIENCE LIMITED | Amministratore Delegato | 01/01/2003 |
Hong Kong Genome Institute | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Shui On Leung
| Società | Posizione | Fine |
|---|---|---|
Novelmab Ltd. | Direttore/Membro del Consiglio | 01/07/2018 |
The Hong Kong Institute of Biotechnology Ltd. | Amministratore Delegato | 01/08/2003 |
| IMMUNOMEDICS, INC. | Corporate Officer/Principal | 01/07/2000 |
Formazione di Shui On Leung
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
96
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Chinese University of Hong Kong
 The Chinese University of Hong Kong Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Hong Kong Institute of Biotechnology Ltd. | |
Sinomab Bioscience Ltd.
 Sinomab Bioscience Ltd. BiotechnologyHealth Technology Manufactures and distributes antibodies | Health Technology |
Novelmab Ltd. | |
Hong Kong Genome Institute |
